Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance

Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance

Abstract Introduction Afghanistan added ROTARIX to the routine national immunization programme in 2018. We aimed to estimate the cost-effectiveness and benefit-risk of ROTARIX and compare its continued use with other rotavirus vaccines that could be used in the future. Methods We used a static cohor...

Full description

Saved in:
Bibliographic Details
Main Authors: Palwasha Anwari, Frédéric Debellut, Sardar Parwiz, Clint Pecenka, Andrew Clark
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Health Services Research
Subjects:
Rotavirus vaccine
Cost-utility
Cost-effectiveness
Benefit-risk
Rotavirus gastroenteritis
Afghanistan
Online Access:https://doi.org/10.1186/s12913-025-12885-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items